These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22153674)

  • 1. Glucocorticoid-induced osteoporosis: when and who should we treat?
    Morel G; Biver E; Borg S; Chopin F; Hoppé E; Rajzbaum G
    Joint Bone Spine; 2011 Dec; 78 Suppl 2():S214-7. PubMed ID: 22153674
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of glucocorticoid-induced osteoporosis: lessons for clinical practice.
    Roux C; Rajzbaum G; Morel G; Legrand E; Laroche M; Hoppé E; Chopin F; Borg S; Biver E; Cortet B; Thomas T
    Joint Bone Spine; 2011 Dec; 78 Suppl 2():S222-6. PubMed ID: 22153676
    [No Abstract]   [Full Text] [Related]  

  • 3. Selecting the optimal treatment for glucocorticoid-induced osteoporosis.
    Chopin F; Hoppé E; Morel G; Biver E; Borg S; Thomas T
    Joint Bone Spine; 2011 Dec; 78 Suppl 2():S218-21. PubMed ID: 22153675
    [No Abstract]   [Full Text] [Related]  

  • 4. [New development in bisphosphonate treatment. Bisphosphonates for the treatment of glucocorticoid-induced osteoporosis].
    Soen S
    Clin Calcium; 2009 Jan; 19(1):44-53. PubMed ID: 19122264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of glucocorticoid-induced osteoporosis: What is new?
    Compston J
    Int J Rheum Dis; 2019 Sep; 22(9):1595-1597. PubMed ID: 31478605
    [No Abstract]   [Full Text] [Related]  

  • 6. Male osteoporosis: who should be treated and how?
    Biver E; Borg S; Chopin F; Hoppé E; Morel G; Cortet B
    Joint Bone Spine; 2011 Dec; 78 Suppl 2():S202-7. PubMed ID: 22153671
    [No Abstract]   [Full Text] [Related]  

  • 7. [Basics and management of glucocorticoid-induced osteoporosis].
    Willenberg HS; Lehnert H
    Internist (Berl); 2008 Oct; 49(10):1186-90, 1192, 1194-6. PubMed ID: 18758741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of glucocorticoid induced osteoporosis].
    Arazzi M; Di Fulvio G; Di Pietro LO; Grabocka X; Longo MO; Micioni G; Pezzutto A; Piscitani L; Schiazza A; Silvestri S; Vigilante G; Amoroso L; Bonomini M
    G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of teriparatide in treatment of glucocorticoid-induced osteoporosis].
    Soen S
    Clin Calcium; 2012 Mar; 22(3):315-20. PubMed ID: 22370297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid-induced Osteoporosis.
    Whittier X; Saag KG
    Rheum Dis Clin North Am; 2016 Feb; 42(1):177-89, x. PubMed ID: 26611558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Active vitamin D3 therapy for gulucocorticoid-induced osteoporosis].
    Nakayama H
    Clin Calcium; 2006 Jul; 16(7):1201-7. PubMed ID: 16816482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should bisphosphonates be used for long-term treatment of glucocorticoid-induced osteoporosis?
    Teitelbaum SL; Seton MP; Saag KG
    Arthritis Rheum; 2011 Feb; 63(2):325-8. PubMed ID: 21279986
    [No Abstract]   [Full Text] [Related]  

  • 13. [Assessment of the treatment of glucocorticoid-induced osteoporosis].
    Asano S; Suzuki A
    Clin Calcium; 2013 Mar; 23(3):401-8. PubMed ID: 23445894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid-induced osteoporosis.
    Reid IR
    Osteoporos Int; 1997; 7 Suppl 3():S213-6. PubMed ID: 9536335
    [No Abstract]   [Full Text] [Related]  

  • 15. Suboptimal osteoporosis management: moving beyond detection.
    Neogi T; Allison JJ
    J Rheumatol; 2004 Mar; 31(3):413-5. PubMed ID: 14994380
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions.
    Bultink IE; Baden M; Lems WF
    Expert Opin Pharmacother; 2013 Feb; 14(2):185-97. PubMed ID: 23317448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of bisphosphonates for prevention of fracture related to glucocorticoid-induced osteoporosis in Malaysia.
    Mohd-Tahir NA; Thomas P; Mohamed-Said MS; Makmor-Bakry M; Li SC
    Int J Rheum Dis; 2018 Mar; 21(3):647-655. PubMed ID: 29105349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiology of corticosteroid-induced osteoporosis].
    Braun J
    Z Rheumatol; 2001 Apr; 60(2):107-10. PubMed ID: 11383044
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucocorticoid osteoporosis.
    Sambrook PN
    Curr Pharm Des; 2002; 8(21):1877-83. PubMed ID: 12171526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in treatment of glucocorticoid-induced osteoporosis.
    Hsu E; Nanes M
    Curr Opin Endocrinol Diabetes Obes; 2017 Dec; 24(6):411-417. PubMed ID: 28857847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.